Literature DB >> 25422179

microRNA-29b: an emerging player in human cancer.

Hao Liu1, Bin Wang, Jie Lin, Liang Zhao.   

Abstract

MicroRNAs (miRNAs) are ubiquitously expressed small, non-coding RNAs that negatively regulate gene expression at a post transcriptional/translational level. They have emerging as playing crucial roles in cancer at all stages ranging from initiation to metastasis. As a tumor suppressor miRNA, aberrant expression of microRNA-29b (miR-29b) has been detected in various types of cancer, and its disturbance is related with tumor development and progression. In this review, we summarize the latest findings with regard to the tumor suppressor signature of miR-29b and its regulatory mechanisms. Our review highlights the diverse relationships between miR-29b and its target genes in malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25422179     DOI: 10.7314/apjcp.2014.15.21.9059

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  Mesenchymal stem cells correct impaired diabetic wound healing by decreasing ECM proteolysis.

Authors:  Junwang Xu; Carlos Zgheib; Maggie M Hodges; Robert C Caskey; Junyi Hu; Kenneth W Liechty
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

2.  miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia.

Authors:  Shaheen Durrani-Kolarik; Caylie A Pool; Ashley Gray; Kathryn M Heyob; Mary J Cismowski; Gloria Pryhuber; L James Lee; Zhaogang Yang; Trent E Tipple; Lynette K Rogers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-04       Impact factor: 5.464

3.  CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.

Authors:  Mohit Jain; Shailesh D Ingole; Rahul S Deshmukh; Simin V Bharucha; Anagha S Nagvekar; Rajiv V Gaikwad; Shambhudeo D Kharde
Journal:  Chromosome Res       Date:  2021-02-27       Impact factor: 5.239

4.  In Silico Study of miRNA Based Gene Regulation, Involved in Solid Cancer, by the Assistance of Argonaute Protein.

Authors:  Surya Narayan Rath; Debasrita Das; V Badireenath Konkimalla; Sukanta Kumar Pradhan
Journal:  Genomics Inform       Date:  2016-09-30

5.  Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins.

Authors:  Maryna Perepelyuk; Christina Maher; Ashakumary Lakshmikuttyamma; Sunday A Shoyele
Journal:  Int J Nanomedicine       Date:  2016-07-28

6.  Downregulation of miR‑29b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer.

Authors:  Li-Hua Wang; Ju Huang; Cheng-Rong Wu; Liu-Ye Huang; Jun Cui; Zhi-Zhi Xing; Chun-Yu Zhao
Journal:  Mol Med Rep       Date:  2017-11-23       Impact factor: 2.952

7.  An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.

Authors:  Sayyed K Zaidi; Andrew W Perez; Elizabeth S White; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Oncotarget       Date:  2017-06-20

8.  KRAS-driven miR-29b expression is required for tumor suppressor gene silencing.

Authors:  Shilpa Thakur; Charles Brenner
Journal:  Oncotarget       Date:  2017-08-19

9.  Long noncoding RNA TUG1 promotes proliferation and inhibits apoptosis in multiple myeloma by inhibiting miR-29b-3p.

Authors:  Dahai Liu; Jianfeng Wang; Meihan Liu
Journal:  Biosci Rep       Date:  2019-03-22       Impact factor: 3.840

10.  Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway.

Authors:  Dongyang Gao; Qian Niu; Yuwen Gong; Qi Guo; Su Zhang; Yuhan Wang; Shanhui Liu; Hanzhang Wang; Robert Svatek; Ronald Rodriguez; Junhai Ma; Zhiping Wang
Journal:  J Oncol       Date:  2021-07-01       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.